ENHANZE® Drug Delivery Technology: A Novel Approach to Subcutaneous Administration Using Recombinant Human Hyaluronidase 20

Drug Delivery - United Kingdom
doi 10.1080/10717544.2018.1551442
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

Use of Recombinant Human Hyaluronidase-Facilitated Subcutaneous Immunoglobulin in Elderly Patients

Immunotherapy
OncologyAllergyImmunology
2020English

Subcutaneous Administration of Rituximab (MabThera) and Trastuzumab (Herceptin) Using Hyaluronidase

British Journal of Cancer
Cancer ResearchOncology
2013English

A New 20% Concentration Immunoglobulin for Subcutaneous Administration (IGSC 20%)

Journal of Allergy and Clinical Immunology
AllergyImmunology
2019English

Ethosomes: A Novel Approach for Transdermal Drug Delivery

International Journal of ChemTech Research
2018English

A Novel Approach in Mucoadhesive Drug Delivery System to Improve Zidovudine Intestinal Permeability

Brazilian Journal of Pharmaceutical Sciences
ToxicologyPharmaceuticsPharmacology
2016English

Novel Methods for Intranasal Administration Under Inhalation Anesthesia to Evaluate Nose-To-Brain Drug Delivery

Journal of Visualized Experiments
ImmunologyMolecular BiologyBiochemistryMicrobiology Chemical EngineeringNeuroscienceGenetics
2018English

Microcapsule: A Dosage Form for Drug Delivery in Novel Drug Delivery System

International Journal of Current Research and Academic Review
2016English

Targeting Anticancer Drug Delivery to Pancreatic Cancer Cells Using a Fucose-Bound Nanoparticle Approach

PLoS ONE
Multidisciplinary
2012English

Microneedles Drug Delivery: Polymeric Microneedle Arrays: Versatile Tools for an Innovative Approach to Drug Administration (Adv. Therap. 8/2019)

Advanced Therapeutics
BiochemistryMedicineGeneticsPharmacologyPharmaceutical Science
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy